Research map: From image reconstruction to clinical prognosis: A comprehensive analysis of centiloid-based amyloid PET assessment

Back to the article

Papers in this map

  1. Index for rating diagnostic tests · W. J. Youden · 1950 · 11816 citations · Cited by this paper
  2. Real-world evaluation of [177Lu]Lu-PSMA-617 RLT in post-taxane mCRPC: feasibility and safety of individualized treatment in a challenging cohort · 2026 · Related
  3. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease · Marilyn S. Albert · 2011 · 10433 citations · Cited by this paper
  4. Whole-body TSPO-PET reveals stage-dependent disruption of systemic immune organ interactions in glioblastoma · 2026 · Related
  5. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B · William E. Klunk · 2004 · 4530 citations · Cited by this paper
  6. Evaluation of treatment efficacy of the 161Tb- and 177Lu-Labeled GRPR antagonists AMTG and RM2 in a mouse model of prostate cancer · 2026 · Related
  7. Phases of Aβ-deposition in the human brain and its relevance for the development of AD · Dietmar Rudolf Thal · 2002 · 3614 citations · Cited by this paper
  8. [18F]FDG PET during immunotherapy: mind the gap between evidence, imaging guidelines, and oncology practice · 2026 · Related
  9. The neuropathological diagnosis of Alzheimer’s disease · Michael A. Deture · 2019 · 3468 citations · Cited by this paper
  10. CSF proteomic pathway alterations and caudate dopamine transporter deficits predict cognitive vulnerability in early Parkinson’s disease · 2026 · Related
  11. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET · William E. Klunk · 2014 · 1406 citations · Cited by this paper
  12. Skeletal muscle radiodensity as an automated survival predictor in men with metastatic castration-resistant prostate cancer undergoing PSMA-targeted radioligand therapy · 2026 · Related
  13. Use of Florbetapir-PET for Imaging β-Amyloid Pathology · Christopher M. Clark · 2011 · 1125 citations · Cited by this paper
  14. In vivo multimodal PET/MRI imaging and plasma biomarkers implicate glymphatic dysfunction linking neuroinflammation to tau pathology in the early Alzheimer’s disease continuum · 2026 · Related
  15. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study · Osama Sabri · 2015 · 630 citations · Cited by this paper
  16. Prospective comparison of [68Ga]Ga-FAPI-04 PET/MRI, [18F]FDG PET/CT, and contrast-enhanced MRI for predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer · 2026 · Related
  17. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study · Henryk Barthel · 2011 · 596 citations · Cited by this paper
  18. 68Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data · 2026 · Related
  19. Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density · Craig T Curtis · 2015 · 345 citations · Cited by this paper
  20. Personalized metabolic connectome analysis reveals glucose heterogeneity in ischemic cerebrovascular disease · 2026 · Related
  21. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0 · Satoshi Minoshima · 2016 · 268 citations · Cited by this paper
  22. The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review · Marianne Chapleau · 2022 · 266 citations · Cited by this paper
  23. Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach · for the Alzheimer’s Disease Neuroimaging Initiative · 2021 · 250 citations · Cited by this paper
  24. Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale · Michael A. Navitsky · 2018 · 240 citations · Cited by this paper
  25. Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease · Sanka Amadoru · 2020 · 189 citations · Cited by this paper
  26. Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET · Renaud La Joie · 2020 · 138 citations · Cited by this paper
  27. Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods · Mark R Battle · 2018 · 132 citations · Cited by this paper
  28. Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium · Lyduine Eisa Collij · 2024 · 114 citations · Cited by this paper
  29. Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease · Stephen Salloway · 2017 · 94 citations · Cited by this paper
  30. Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study · Bernard Jimmy Hanseeuw · 2020 · 89 citations · Cited by this paper
  31. rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data · Leonardo Iaccarino · 2021 · 64 citations · Cited by this paper
  32. Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition · Samantha C. Burnham · 2020 · 53 citations · Cited by this paper
  33. Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology · Mahnaz Shekari · 2024 · 51 citations · Cited by this paper
  34. SNMMI Procedure Standard/EANM Practice Guideline for Brain [ 18 F]FDG PET Imaging, Version 2.0 · Javier Arbizu · 2024 · 47 citations · Cited by this paper
  35. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods · Aleksandar Jovalekic · 2023 · 43 citations · Cited by this paper
  36. Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan · Mahnaz Shekari · 2023 · 39 citations · Cited by this paper
  37. Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study · Ariane Bollack · 2024 · 37 citations · Cited by this paper
  38. β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3 · Pierrick Bourgeat · 2022 · 36 citations · Cited by this paper
  39. Concordance Between Amyloid-PET Quantification and Real-World Visual Reads · Ehud Zeltzer · 2025 · 32 citations · Cited by this paper

Source: OpenAlex (CC0)